在缺氧诱导疾病模型中,LncRNA H19和miR-138调节视网膜新血管化和相关的病理特征
1Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Experimental eye research
|July 7, 2025
概括
长非编码RNA H19和microRNA-138调节了视网膜新血管化的过程. 向H19和miR-138通过减少病理变化和关键因子水平,为眼部疾病提供了潜在的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 视网膜神经血管疾病是导致视力丧失的主要原因.
- 像H19这样的长非编码RNAs (lncRNAs) 在这些疾病中的作用尚未完全理解.
- 确定新的治疗点对于治疗这些疾病至关重要.
研究的目的:
- 研究lncRNA H19在视网膜新血管化的作用机制.
- 评估lncRNA H19和microRNA-138 (miR-138) 作为潜在的治疗点.
- 探索H19,miR-138和关键疾病因素之间的调节关系.
主要方法:
- 建立了一个氧气诱导视网膜病变 (OIR) 的小鼠模型.
- 利用腺病毒介导的H19和miR-138的淘汰和过度表达.
- 进行RT-qPCR,血素和欧染色,西斑,免疫组织化学和免疫光.
- 在低氧条件下使用培养的人类视网膜内皮细胞 (HREC) 研究了体外效应.
- 进行了化酶测定,以确认直接结合相互作用.
主要成果:
- 在OIR模型和低氧HREC中,lncRNA H19显著上调,而miR-138在OIR模型和低氧HREC中显著下调.
- 对H19的抑制和miR-138的过度表达减少了视网膜病理变化.
- 在H19倒置和miR-138过度表达后,VEGF和HIF-1α水平下降.
- 发现miR-138直接针对H19和HIF1α.
结论:
- lncRNA H19和miR-138在调节视网膜新血管化的过程中起着至关重要的作用.
- miR-138通过直接向H19和HIF1α以及通过竞争性吸附来发挥其作用.
- 调节H19/miR-138轴为视网膜神经血管疾病提供了一个有前途的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Mechanism of Angiogenesis
5.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.9K


